Darrin Smith - 31 Aug 2026 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Sep 2026, 17:49:25 UTC
Prior SEC filing
02 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Costa, as Attorney-in-Fact

Key filing fact

Darrin Smith filed Form 4 for Sabra Health Care REIT, Inc. (SBRA) on 02 Sep 2026.

Key facts

  • This page summarizes Darrin Smith's Form 4 filing for Sabra Health Care REIT, Inc. (SBRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Sep 2026, 17:49.

Change

  • Previous filing in this sequence was filed on 02 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002104848 Primary reporting owner

Smith Darrin

Relationship
Executive VP, CIO & Secretary
Address
C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN
Signature
/s/ Michael Costa, as Attorney-in-Fact
Signature date
02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBRA transaction

Common Stock

Award

Transaction value
Shares
+495
Change %
+0.43%
Price
$0.000000*
Shares after
116,919
Date
31 Aug 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

Footnote F2

Includes 34,182 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .